PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.
Show more...
FAQ
PRF Technologies 今天的股價是多少?▼
PRFX.BOATS 目前價格為 $1.99 USD,過去 24 小時上漲了 +1.53%。在圖表上更密切關注 PRF Technologies 股價表現。
PRF Technologies 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,PRF Technologies 的股票以代號 PRFX.BOATS 進行交易。
PRF Technologies 的市值是多少?▼
今天 PRF Technologies 的市值為 4.01M
PRF Technologies 去年的營收是多少?▼
PRF Technologies 去年的營收為 0USD。
PRF Technologies 去年的淨利是多少?▼
PRFX.BOATS 去年的淨收益為 -29.18MUSD。
PRF Technologies 有多少名員工?▼
截至 April 01, 2026,公司共有 2 名員工。
PRF Technologies 位於哪個產業?▼
PRF Technologies從事於Health Care產業。
PRF Technologies 何時完成拆股?▼
PRF Technologies 上次拆股發生於 February 06, 2026,比例為 1:5。
PRF Technologies 的總部在哪裡?▼
PRF Technologies 的總部位於 IL 的 Tel Aviv。